<--- Back to Details
First PageDocument Content
Biology / Chemical pathology / Medical emergencies / Heart-type fatty acid binding protein / Biomarkers / Aging-associated diseases / Myocardial infarction diagnosis / Medicine / Health / Cardiology
Biology
Chemical pathology
Medical emergencies
Heart-type fatty acid binding protein
Biomarkers
Aging-associated diseases
Myocardial infarction diagnosis
Medicine
Health
Cardiology

Diagnostic Evidence Co-operative Oxford Cooperative Oxford HR Diagnostics Evidence Cooperative Point-of-care testing Oxford

Add to Reading List

Source URL: www.oxford.dec.nihr.ac.uk

Download Document from Source Website

File Size: 649,59 KB

Share Document on Facebook

Similar Documents

ONCOLOGY REPORTS 39: , 2018  Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review) Taxiarchis Konstantinos Nikolouzakis1, Loukia Vassilopoulou2, Persefoni Fragkiadaki2, Theod

ONCOLOGY REPORTS 39: , 2018 Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review) Taxiarchis Konstantinos Nikolouzakis1, Loukia Vassilopoulou2, Persefoni Fragkiadaki2, Theod

DocID: 1vf63 - View Document

NEWS: How to use quantitative LC-MS/MS proteomics to study skin conditions A recent study (1) showed how quantitative LC-MS/MS proteomics allowed to find biomarkers candidates by comparison of skin biopsies from psoriasi

NEWS: How to use quantitative LC-MS/MS proteomics to study skin conditions A recent study (1) showed how quantitative LC-MS/MS proteomics allowed to find biomarkers candidates by comparison of skin biopsies from psoriasi

DocID: 1vdFN - View Document

TECHNOLOGY OFFER Novel platelet biomarkers for detection of thrombosis risk We hereby present novel biomarkers for the detection of platelet reactivity. These new biomarkers allow the risk estimation for people having a

TECHNOLOGY OFFER Novel platelet biomarkers for detection of thrombosis risk We hereby present novel biomarkers for the detection of platelet reactivity. These new biomarkers allow the risk estimation for people having a

DocID: 1v9bO - View Document

Invitation to the  NANO WORLD CANCER DAY 2018 Precision Medicine for People – Smart Biomarkers, Nanotechnologies and more Date:

Invitation to the NANO WORLD CANCER DAY 2018 Precision Medicine for People – Smart Biomarkers, Nanotechnologies and more Date:

DocID: 1v8gO - View Document

BioCog_Brochure_Project_def_Layout:52 Pagina 1  BioCog is a FP7 project funded by the European Commission with the final aim of establishing valid biomarkers panels for risk analysis and clinical outcome pr

BioCog_Brochure_Project_def_Layout:52 Pagina 1 BioCog is a FP7 project funded by the European Commission with the final aim of establishing valid biomarkers panels for risk analysis and clinical outcome pr

DocID: 1v5iF - View Document